GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Probiotix Health PLC (AQSE:PBX) » Definitions » Debt-to-Asset

Probiotix Health (AQSE:PBX) Debt-to-Asset : 0.00 (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Probiotix Health Debt-to-Asset?

Probiotix Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was £0.00 Mil. Probiotix Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was £0.00 Mil. Probiotix Health's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2023 was £2.49 Mil. Probiotix Health's debt to asset for the quarter that ended in Jun. 2023 was 0.00.


Probiotix Health Debt-to-Asset Historical Data

The historical data trend for Probiotix Health's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Probiotix Health Debt-to-Asset Chart

Probiotix Health Annual Data
Trend Dec18 Dec19 Dec20 Dec22
Debt-to-Asset
- 1.07 1.04 -

Probiotix Health Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Jun22 Dec22 Jun23
Debt-to-Asset Get a 7-Day Free Trial 1.04 - - - -

Competitive Comparison of Probiotix Health's Debt-to-Asset

For the Biotechnology subindustry, Probiotix Health's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Probiotix Health's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Probiotix Health's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Probiotix Health's Debt-to-Asset falls into.



Probiotix Health Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Probiotix Health's Debt-to-Asset for the fiscal year that ended in Dec. 2022 is calculated as

Probiotix Health's Debt-to-Asset for the quarter that ended in Jun. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Probiotix Health  (AQSE:PBX) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Probiotix Health Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Probiotix Health's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Probiotix Health (AQSE:PBX) Business Description

Traded in Other Exchanges
Address
Nostell Business Estate, First Floor Zucchi Suite, Wakefield, GBR, WF4 1AB
Probiotix Health PLC develops probiotics to tackle cardiovascular disease and other lifestyle conditions which are affecting growing numbers of people across the world. The Company has one class of business, in three geographical areas being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry.

Probiotix Health (AQSE:PBX) Headlines

No Headlines